- Filed
- May 19, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 17.17M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 16.48M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 4.59M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.31M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.27M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $174.56K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.49M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $13.48M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $15.2M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $737.61K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $890.57K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $974.57K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $890.57K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $212.47K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.55M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $14.45M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $16.09M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.22 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.22 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.05M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.54M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.4M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.84M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.13M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$4.58M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $29K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $62.06K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $8.22K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $24.74K |
| Revenue | Q1 2026 · Mar 31, 2026 | $67.86K |
| Revenue | Q1 2026 · Mar 31, 2025 | $109.31K |